We are pleased to offer upgraded features that further reinforce NovoPath’s firm commitment toward providing a more streamlined workflow, increased flexibility in both operations and reporting, and an overall reduction in human introduced error.
Princeton, NJ (PRWEB) May 31, 2012
NovoPath, Inc., a leader in Anatomic Pathology Best-of-Breed Software Solutions, announces the release of NovoPath 8.0, strengthening the competitive edge NovoPath provides for their growing list of laboratory partners. The enhancements to this state-of-the-art software system include features that streamline workflow, ensure greater accuracy, increase flexibility, reduce review and sign-out time for reports, while providing the Pathology Lab the capability to help in meeting the CMS Meaningful Use Critera.
Enhanced features found in NovoPath 8.0 include:
RTF (Rich Text Format) Support
Preserves formatting when entering free text during grossing, microscopic analysis, diagnostic interpretation, and additional comments
Minimizes typing error rate – corrections are automatically incorporated
Revised Results Screen
Provides a more intuitive experience and simplified access to Special Stain ordering
Fast Case Preview
In less than 1 second the overall report is viewed with write-back and released for rapid sign-out
Provides a route to bypass report generation for Batch Electronic Release
“The deployment of NovoPath 8.0 is a direct result of our close collaboration with a broad range of customers,” said Rick Callahan, VP of Sales and Marketing at NovoPath. “We are pleased to offer upgraded features that further reinforce NovoPath’s firm commitment toward providing a more streamlined workflow, increased flexibility in both operations and reporting, and an overall reduction in human introduced error.”
About NovoPath, Inc.:
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.